Logo

JP Morgan

Hologic Aims to Expand Global Reach With Focus on Women's Health

At the JP Morgan Healthcare conference, CEO Steve MacMillan especially noted Africa as an underserved market for women's health.

PerkinElmer Becoming Pure Play Dx, Life Science Firm, Spurred on by COVID Innovations

At the JP Morgan conference, the firm's CEO said that it chose to divest its applied, food, and enterprise businesses due to innovations it achieved during the pandemic. 

Myriad Genetics Highlights 2023 Product Launches for Women's Health, Oncology Businesses
Premium

The company is planning to launch a 4-in-1 prenatal screening test, a liquid biopsy test, and a minimal residual disease assay in the coming year.

Morgan Health Invests $20M in LetsGetChecked

Morgan Health CEO Dan Mendelson said that the investment was in line with the business unit's focus on employee health.

UBS, JP Morgan Downgrade Singular Genomics to Neutral

Analysts for the two banks cited supply chain and manufacturing issues that have delayed the launch of the G4 sequencing instrument as key reasons for the downgrade.

Aug 11, 2022

JP Morgan Downgrades Seer to Neutral

Jan 12, 2022

JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More

Nov 10, 2021

JP Morgan Initiates Coverage of Oxford Nanopore Technologies With Overweight Rating

Aug 25, 2021

PerkinElmer Reaches Deal for $1.5B Credit Facility

Aug 17, 2021

JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings

Aug 12, 2021

PerkinElmer Enters $500M Credit Facility

Jun 21, 2021

JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems

May 24, 2021

Singular Genomics Ups IPO Target to $187M

May 12, 2021

Sequencing Startup Singular Genomics Files for $100M IPO

Feb 18, 2021

Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Jan 13, 2021

JP Morgan Healthcare Conference 2021, Day 2: Qiagen, Invitae, Agilent, Sema4, More

Jan 13, 2021

At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing

Jan 12, 2021

Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition
Premium

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 1: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Jan 11, 2021

PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan

Dec 3, 2020

Twist Bioscience Prices Upsized $300M Public Offering

Dec 2, 2020

Twist Bioscience Proposes $250M Public Offering

Nov 3, 2020

Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations
Premium

Oct 14, 2020

JP Morgan Rates Invitae Neutral

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.